Form 4: SCPharmaceuticals Director Acquires Stock Options
SEC Form 4 Filing
Director Jack A. Khattar acquired 19,750 stock options in scPharmaceuticals Inc. on June 11, 2024.
Summary
- On June 11, 2024, Jack A. Khattar, a director of scPharmaceuticals Inc., acquired 19,750 stock options.
- The options have an exercise price of $4.11.
- The options vest in full upon the earlier of June 11, 2025, or the next annual meeting of the Issuer's stockholders.
- The options expire on June 11, 2034.
- Following the transaction, Khattar directly owns 19,750 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports a transaction.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction provides information to shareholders about the holdings of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the stock option transaction. |
| 06/11/2025 | Earliest vesting date for the stock options. |
| 06/11/2034 | Expiration date for the stock options. |
| 06/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.